Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Complete list of metadatas

https://hal.univ-brest.fr/hal-02055852
Contributor : Ghislaine Calvez <>
Submitted on : Monday, March 4, 2019 - 12:12:42 PM
Last modification on : Thursday, July 25, 2019 - 2:24:48 PM

Identifiers

  • HAL Id : hal-02055852, version 1

Citation

Jean-Guillaume Dillinger, Boris Aleil, Saida Cheggour, Ygal Benhamou, Yannick Béjot, et al.. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2018, 111 (2), pp.85-94. ⟨hal-02055852⟩

Share

Metrics

Record views

30